Page last updated: 2024-10-29

ketoconazole and Nephrosis, Lipoid

ketoconazole has been researched along with Nephrosis, Lipoid in 2 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Nephrosis, Lipoid: A kidney disease with no or minimal histological glomerular changes on light microscopy and with no immune deposits. It is characterized by lipid accumulation in the epithelial cells of KIDNEY TUBULES and in the URINE. Patients usually show NEPHROTIC SYNDROME indicating the presence of PROTEINURIA with accompanying EDEMA.

Research Excerpts

ExcerptRelevanceReference
"Cyclosporine treatment in children with minimal change nephrotic syndrome is effective in preventing relapse and decreasing steroid toxicity."1.35Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children. ( El-Dahshan, K; El-Husseini, A; Sabry, A; Sobh, M, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sabry, A2
El-Husseini, A2
El-Dahshan, K1
Sobh, M2
El-Basuony, F1
Donia, A1
Mahmoud, I1
Hassan, N1
Sayed-Ahmad, N1
Sheashaa, H1

Other Studies

2 other studies available for ketoconazole and Nephrosis, Lipoid

ArticleYear
Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children.
    Iranian journal of kidney diseases, 2009, Volume: 3, Issue:3

    Topics: Antifungal Agents; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Drug Therapy, Combinatio

2009
Co-administration of cyclosporine and ketoconazole in children with minimal change nephrotic syndrome.
    Nephron. Clinical practice, 2005, Volume: 100, Issue:2

    Topics: Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Humans; Ketoconazole; Male

2005